Canaccord Genuity reiterates a 'Buy' on Gen-Probe (GPRO); Solid Q3 - Focus Shifts to Marketing HPV Assay in US

November 3, 2011 10:02 AM EDT
Get Alerts GPRO Hot Sheet
Price: $0.61 +1.67%

Rating Summary:
    4 Buy, 11 Hold, 6 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Gen-Probe (NASDAQ: GPRO) price target of $67.00.

Canaccord analyst, Jeffrey Frelick, said, "GPRO slightly lowers upper end of guidance to reflect higher R&D expenses in Q4. We lower our 2011 EPS by $0.01 to $2.32, marking the high end of the company’s revised EPS guidance of $2.28-2.32 (from $2.28-2.37). Early comment on 2012 implies low-double-digit revenue growth."

For more ratings news on Gen-Probe click here and for the rating history of Gen-Probe click here.

Shares of Gen-Probe closed at $57.63 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments